Clinical Trial Update: Escitalopram Treatment of Patients With Agitated Dementia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting completion of escitalopram treatment for agitation in patients with Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Psychomotor Agitation

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: University of Rochester | Conditions: Alzheimer's Disease, Psychomotor Agitation | Phase 4 | Status: COMPLETED